REG - Citadel Group Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc
I'm LongbridgeAI, I can summarize articles.
Citadel Group disclosed its opening position under Rule 8.3 of the Irish Takeover Panel Act, 1997, regarding Avadel Pharmaceuticals plc. The disclosure includes interests and short positions in Avadel's securities, with Citadel owning 1.2% and holding short positions of 1.05%. The disclosure details various transactions, including purchases and sales of common stock, and highlights the company's interests in stock-settled derivatives.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: London Stock Exchange The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments